NLRP3 and brain edema: Accumulating evidence that NLRP3 inflammasome inhibition could relieve neuroinflammation, disrepute BBB intensity, and reduce cell death in early brain injury [15, 16] make the NLRP3 inflammasome-induced anti-inflammatory treatment be a potential strategy to reduce brain edema.